FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Ambey Laboratories IPO.
September 7, 2024 8:54:00 AM
Two blank check companies also priced this week. Vine Hill Capital (VCICU) raised $200 million to target industrials and service industries. Andretti Acquisition II (POLEU), the second SPAC affiliated ...
Published by : Seeking AlphaSeptember 4, 2024 5:53:00 PM
BioAge�s anticipated move to the public market follows a slight uptick in planned biotech IPOs from Bicara Therapeutics and Zenas Biopharma. Zooming out, the recent IPO landscape is a �mixed picture,� ...
Published by : FierceBiotechSeptember 4, 2024 5:01:00 PM
BioAge will use the proceeds from the initial public offering to move its oral apelin receptor agonist azelaprag past its Phase III STRIDES study and into a registrational Phase III trial.
Published by : BioSpaceSeptember 5, 2024 8:27:00 PM
BioAge Labs, Inc. is seeking $100 million in an IPO to fund its clinical trials for obesity and insulin sensitivity treatments. The company�s lead drug, Azelaprag, is in Phase 2 trials.
Published by : Seeking AlphaSeptember 3, 2024 3:30:00 AM
BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, has filed for an initial public offering.
Published by : Bloomberg L.P.September 4, 2024 6:43:00 PM
BioAge Labs a biotech company focused on therapies for metabolic diseases, has filed for a $100 million IPO. Founded in 2015, the company plans to list on Nasdaq under the symbol BIOA. Their lead drug ...
Published by : Benzinga.comSeptember 7, 2024 3:30:00 AM
A private company can raise capital by selling shares publicly to institutional investors and retail investors through an issuance of new stock, called an initial public offering (IPO).
Published by : InvestopediaAugust 27, 2024 2:38:00 PM
Resourceful Automobile's Rs 12-cr IPO was oversubscribed 419 times, attracting bids worth Rs 4,800 cr. Experts warn of market frenzy and risks associated with SME IPOs.
Published by : money.rediffAugust 23, 2024 5:16:00 PM
Cava priced its IPO at $22 per share, valuing the company at $2.5 billion. (Photo by Spencer Platt/Getty Images) When a company exceeds quarterly growth targets and raises guidance, its stock ...
Published by : ForbesAugust 20, 2024 3:27:00 AM
Pine Labs is India�s fourth most valued fintech company, behind PhonePe, Razorpay and Cred. Reportedly, it is readying for an IPO, which could be the largest by an Indian fintech firm since ...
Published by : MintAugust 13, 2024 5:44:00 PM
Nonetheless, India continued to see a steady rise in the number of Indian companies filing for IPO this month. IPOs filed by Akums Drugs and Pharmaceuticals, Ceigall India, and Ola Electric ...
Published by : ForbesSeptember 3, 2024 4:13:00 AM
Identical Brains Studios, a leading VFX company renowned for its innovative and high-quality work in the film and entertainment industry, announced the filing of its Draft Red Herring Prospectus (DRHP ...
Published by : Equity BullsThe IPO Shares of Ambey Laboratories Limited IPO are proposed to list on Thursday, July 11, 2024 at NSE SME. The public issue of Ambey Laboratories IPO was opened on Jul 4, 2024 and closed for subscription on Jul 8, 2024. Ambey Laboratories IPO Listing Date and Information:
Listing Date | Thursday, July 11, 2024 |
BSE Script Code | |
NSE Symbol | AMBEY |
Listing In | |
ISIN | INE0M3I01029 |
Issue Price | ₹68 Per Equity Share |
Face Value | ₹10 Per Equity Share |
The allotment status of Ambey Laboratories Limited IPO is now available online. The public issue of Ambey Laboratories IPO was open on Jul 4, 2024 and closed for subscription on Jul 8, 2024. The equity shares of the company to be list at NSE SME
.
Ambey Laboratories Limited is entering in the capital market with an IPO of 6,570,000 Equity Shares of Rs 10 aggregating up to Rs 44.68 Crore. The price for the issue has been set at Rs 65 - Rs 68 Per Equity Share.
Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades.
The issue opens on Jul 4, 2024 and closes for subscription on Jul 8, 2024. The equity shares of the company to be list at NSE SME.
The issue of Ambey Laboratories Limited opens on Jul 4, 2024 and closes for subscription on Jul 8, 2024. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 65 - Rs 68 Per Equity Share.
The Ambey Laboratories IPO is proposed to open on July 4, 2024. The IPO application ends on July 8, 2024.
Retail investors can apply in the retail or non-institutional investor category from July 4, 2024 to July 8, 2024. The Ambey Laboratories IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Ambey Laboratories IPO will open for subscription on July 4, 2024. The public issue will close on July 8, 2024.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|